ORBIMED ADVISORS LLC

Holdings History for ADC Therapeutics SA - Common Shares, par value CHF 0.08 per share (ADCT)

Symbol: ADCT on NYSE
Investment type: Equity / Common Shares, par value CHF 0.08 per share
Latest Disclosed Shares Owned: 3,230,797 shares
Security Ownership %: 2.6%

Shares, Excluding Options vs Price

Value, Excluding Options

ORBIMED CAPITAL LLC ownership in ADC Therapeutics SA Common Shares, par value CHF 0.08 per share (ADCT)

17 Feb 2026 - ORBIMED CAPITAL LLC has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 3,230,797 shares of ADC Therapeutics SA Common Shares, par value CHF 0.08 per share (ADCT). This represents 2.6% ownership of the company. In their previous filing dated 14 Feb 2025, ORBIMED ADVISORS LLC had reported owning 3,437,813 shares, indicating a decrease of +6%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
ORBIMED CAPITAL LLC	2.6%	-25%	$11,953,949	3,230,797	-207,016	-6%	$3.70	13G/A	31 Dec 2025	17 Feb 2026, 18:06
ORBIMED CAPITAL LLC	3.6%		$5,019,207	3,437,813			$1.46	13G	31 Dec 2024	14 Feb 2025, 16:35

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0.44%	-0.01%	$20,554,675	5,822,854	-84,497	-1.4%	$3.53	Q4 2025
30 Sep 2025	0.57%	0%	$23,629,404	5,907,351	0		$4.00	Q3 2025
30 Jun 2025	0.4%	-0%	$15,831,701	5,907,351	-61,100	-1%	$2.68	Q2 2025
31 Mar 2025	0.2%	0%	$8,415,516	5,968,451	0		$1.41	Q1 2025
31 Dec 2024	0.25%	+0.06%	$11,877,217	5,968,451	+1,434,650	+32%	$1.99	Q4 2024
30 Sep 2024	0.26%	+0.01%	$14,281,473	4,533,801	+216,977	+5%	$3.15	Q3 2024
30 Jun 2024	0.29%	+0.27%	$13,641,164	4,316,824	+4,316,824	NEW	$3.16	Q2 2024

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.